Dr. Hargraves is Vice President of R&D Portfolio Management at Janssen. Dr. Hargraves will speak about current efforts for educating and enrolling diverse populations in clinical trial and will discuss recent highlights pertaining to diversity in the recent ENSEMBLE COVID vaccine trial.

Dr. Sapna McManus is a Medical Affairs Executive Director at Genentech. She discusses ongoing initiatives that she is involved in to develop external partnering strategies to address health equity issues and ensure patients of color have access to clinical trials and quality care by Advancing Inclusive Research.

Dr Richardae Araojo serves as the Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA). In this role, RADM Araojo provides leadership, oversight, and direction on minority health and health disparity matters for the Agency. Certain populations are less accepting of generics, but this is changing due to generic drug landscape and insurance coverage. How do we ensure that the product is bioequivalent for all populations?